Research Labs

The Stegh Lab aims to understand and therapeutically target the genetic program that underlies the pathogenesis of glioblastoma.

Developing high-throughput technologies to study cell-cell interactions. Decoding the metastatic tumor microenvironment. Identifying therapeutic targets in cancer-stroma interactions to fight metastatic cancer.

Focusing on characterizing the function of brain circuits that control memory and arousal in normal and disease states.

Identify molecular mechanisms of neurodegeneration in Huntington’s disease.

The YE Li Lab investigates both the genetic and epigenetic contributions to human diseases, particularly in brain tumors and neuropsychiatric disorders.

The Zipfel Lab aims to understand the mechanisms driving acute and chronic cerebrovascular diseases, identify new molecular targets, and develop novel therapies that will improve the lives of our patients.